Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
 ««+1  ««-1
 
 
Themis Medicare LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:530199NSE Symbol: THEMISMEDP/E(TTM):0
ISIN Demat:INE083B01024Div & Yield %:0.38EPS(TTM):0
Book Value(Rs):31.2163231Market Cap ( Cr.):1212.44Face Value(Rs):1
    Change Company 
( In Cr)
 Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
INCOME :      
Sales Turnover 405.51381.76354.32394.61230.67201.59
Excise Duty0.000.000.000.000.000.00
Net Sales405.51381.76354.32394.61230.67201.59
Other Income 4.674.7611.506.543.623.47
Stock Adjustments 17.981.577.79-3.061.273.49
Total Income428.16388.09373.61398.09235.56208.55
EXPENDITURE :      
Raw Materials 149.98138.28126.16145.0879.4866.67
Power & Fuel Cost11.8113.4611.8312.1811.3211.49
Employee Cost 96.3882.4166.1551.9739.9944.28
Other Manufacturing Expenses 29.0227.5225.9832.9616.1116.93
Selling and Administration Expenses 60.7751.8444.1534.8521.0022.17
Miscellaneous Expenses 26.4818.2920.3918.8614.167.86
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure374.44331.79294.66295.90182.06169.39
Operating Profit53.7356.2978.96102.1953.5039.15
Interest 10.049.389.568.7712.7112.88
Gross Profit43.6946.9169.4093.4240.7926.27
Depreciation9.9312.2510.499.488.558.27
Profit Before Tax33.7634.6658.9183.9432.2418.00
Tax8.309.2215.0016.750.000.00
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax1.540.700.615.635.632.09
Reported Net Profit23.9224.7543.2961.5626.6215.91
Extraordinary Items 0.000.000.000.000.000.00
Adjusted Net Profit23.9224.7543.2961.5626.6215.91
Adjst. below Net Profit -0.31-0.74-0.43-0.321.46-0.17
P & L Balance brought forward155.50135.6296.7938.9811.98-4.27
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations 4.204.144.033.431.09-0.51
P & L Balance carried down174.91155.50135.6296.7938.9811.98
Dividend0.000.000.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %50.0050.0050.0050.0043.0017.50
Earnings Per Share-Unit Curr2.602.6947.0466.9128.9717.32
Earnings Per Share(Adj)-Unit Curr2.602.694.706.692.901.73
Book Value-Unit Curr31.2229.11269.54227.50164.59135.33